Topics: 340B
From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.
PhRMA Statement on Energy & Commerce Health Subcommittee 340B Hearing.
Today, PhRMA CEO John J. Castellani sent the following statement for the record to the Energy and Commerce Health Subcommittee on the hearing they’re holding on the 340B program:
Topics: 340B
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."